People · Operator
Named in public records as an officer, director or promoter · active 2019–2019 · Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Advanced Bio Development, Inc. | — | Biotech / Pharma | Series A | $28.2M | $435.7M | 2019 |
Sandra Karpman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Sandra Karpman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Miller | 1 | 14 |
| Michael Farello | 1 | 7 |
| Christopher Casgar | 1 | 4 |
| Scott Dahnke | 1 | 2 |
| Joseph Poli | 1 | 2 |
| Michael Tannenbaum | 1 | 2 |
| Mark French | 1 | 2 |
| Jonathan London | 1 | 1 |
| Scott Greene | 1 | 1 |
| M. Todd Bartee | 1 | 1 |
| Kawhi Leonard | 1 | 1 |
| Dennis Robertson | 1 | 1 |
| Ralph Ferrante | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.